检索历史 清除

近年来，介入支气管镜技术的进步为呼吸系统疾病的诊断与治疗带来了更加安全且有效的解决方案。然而，当前用于诊断和治疗肺周围病变（PPL）的技术仍存在一定的局限性。机器人辅助支气管镜（RAB）为克服这些局限性提供了新的解决方案。目前，已有3种RAB获得了美国食品药品监督管理局（FDA）的批准并成功上市，而两种国产RAB正处于研发阶段。本文对各种支气管镜导航技术的优缺点进行了概述，并深入介绍了5种RAB。此外，文章还深入探讨了RAB的优缺点及其未来的发展趋势。

In recent years, advances in interventional bronchoscopy have led to safer and more effective solutions for the diagnosis and treatment of respiratory diseases. However, the techniques currently used to diagnose and treat peripheral pulmonary lesions (PPL) have certain limitations. Robotic-assisted bronchoscopy (RAB) offers a new solution to these limitations. Currently, three RABs have been approved by the US Food and Drug Administration (FDA) and are successfully marketed, while two domestic RABs are in the research and development stage. This article provided an overview of the advantages and disadvantages of various techniques and introduced five RABs in detail. It also discussed the advantages and disadvantages of RAB technology and future trends in its development.